CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT
Date
2011Author
Sartor, A. O.
Ozguroglu, M.
Gravis, G.
Shen, L.
de Bono, J. S.
Tombal, B.
Oudard, S.
Hansen, S.
Kocak, I
Metadata
Show full item recordCollections
- Makale [92796]